---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-165676"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:01:28.039710+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anthem reaffirms FY 2022 adjusted net income >$28.40/share

## Summary
- Full-year 2022 net income guidance >$26.43 per share, including ~$1.97/share net unfavorable items.
- Excluding unfavorable items, adjusted net income expected >$28.40 per share.
- Guidance excludes adjustments beyond those reported in Q1 2022 earnings release.
- Officers will speak with investors over the next several weeks, reaffirming this outlook.

## SEC filing metadata
- accession: 0001193125-22-165676
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312522165676/0001193125-22-165676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312522165676/d358893d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-165676
- JSON: https://secwatch.observer/filing/0001193125-22-165676.json
- Plain text: https://secwatch.observer/filing/0001193125-22-165676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.